Friday, July 10, 2026

Drug profile · INN

colestyramine

colestyramine (QUESTRAN LITE) is a bile acids sequestering agent. Associated with Viatris Pharmaceuticals Co.,.

TGA: approved
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — colestyramine

Quick answer

colestyramine (QUESTRAN LITE) is a bile acids sequestering agent. Associated with Viatris Pharmaceuticals Co.,.

Key facts

INN colestyramine
Brand QUESTRAN LITE
Mechanism Bile acids sequestering agent
Target Bile acids

Mechanism of action

Bile acids sequestering agent

Primary target: Bile acids

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. CLOU064C12301 Phase 3 · Novartis India · Multiple Sclerosis
  2. CLOU064C12302 Phase 3 · Novartis India · Multiple Sclerosis
  3. EFC17919B Phase 3 · Sanofi-Aventis U.S · multiple sclerosis
  4. LTS17043 Phase 3 · Sanofi-Aventis U.S · Nervous system diseases
  5. LTS17043 Phase 3 · Sanofi-Aventis U.S · Nervous system diseases

Related & competitor drugs

  1. cholestyramine Bile acids sequestering agent
  2. colesevelam hydrochloride Bile acids sequestering agent
  3. colestipol hydrochloride Bile acids sequestering agent

Frequently asked questions

What is colestyramine?

colestyramine (QUESTRAN LITE) is a bile acids sequestering agent. Associated with Viatris Pharmaceuticals Co.,.

What is the brand name for colestyramine?

QUESTRAN LITE is a marketed brand name for colestyramine. Check FDA Drugs@FDA for the current US label holder and prescribing information.